AzTrials
AzTrials

Cerebral Palsy (CP)NCT07180017

A Survey of Turkish Pediatric Physical Therapists

An observational study of Cerebral Palsy (CP) and Survey, run by Kahramanmaras Sutcu Imam University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

CP encompasses a group of persistent disorders of movement and posture development resulting from injury to the developing brain. Thanks to preventive measures and advances in obstetric and neonatal care, the incidence and severity of CP are currently decreasing in some countries, and the use of early diagnosis… Read more about this study

Who is it for?
Ages 25 to 50 yearsHealthy volunteers can take part
Conditions the study is for
Cerebral Palsy (CP), Survey, Detection
How many people
105 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Mar 2023to 30 Apr 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 to 50 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: All pediatric physiotherapists working in different cities in Turkey, reached through social media under the leadership of the therapists of the Developmental Physiotherapy and Pediatric Rehabilitation Unit of Gazi University Department of Physiotherapy and Rehabilitation

Who may be able to join

  • All literate pediatric physiotherapists between the ages of 25-50 working in different provinces in Turkey

Who cannot join

  • Physiotherapists with no experience in pediatric physiotherapy

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Kahramanmaraş Sütçü imam University

    Kahramanmaraş, Onikişubat, 46100

Other trials in Turkey (Türkiye)

About this study

Official title: Use of Tools for Early Detection of Cerebral Palsy: A Survey of Turkish Pediatric Physical Therapists

CP encompasses a group of persistent disorders of movement and posture development resulting from injury to the developing brain. Thanks to preventive measures and advances in obstetric and neonatal care, the incidence and severity of CP are currently decreasing in some countries, and the use of early diagnosis guidelines or protocols in follow-up units highlights the potential for faster recovery. A 2017 clinical review of early diagnosis tools, published by a group of international experts with best practice recommendations, called for earlier diagnosis through timely use of recommended tools. The diagnosis of CP is typically made by a physician between 12 and 24 months of age, but in some cases, it is delayed until 42 months. Early identification of a high risk of CP relies on a combination of a detailed patient history, developmental assessment, a structured and validated neurological examination or neuromotor assessment, and brain imaging studies. Conversely, the accurate and early use of key tools for early diagnosis can allow for much earlier detection of CP in infants younger than or older than 5 months.According to international guidelines, infants at high risk of CP should be monitored. This monitoring should be conducted by an interdisciplinary team, including a neonatologist, pediatrician, pediatric neurologist, pediatric physiotherapist, speech-language-swallowing therapist, and special education specialist. Pediatric physiotherapists are a crucial part of this team for developmental follow-up and rehabilitation. Therefore, it is important that pediatric physiotherapists in our country have sufficient awareness in this field, are equipped with various training programs, and reach international standards. This allows them to provide early guidance to families at risk of CP, facilitate early diagnosis of CP, and initiate treatment.The aim of this study was to evaluate the use of early diagnostic assessment tools in pediatric physiotherapy practice in Turkey for infants aged 0-2 years at risk for cerebral palsy (CP). Best practice guidelines worldwide recommend the timely use of key assessment tools to reduce the age at which CP is diagnosed. In this context, a digital survey administered to pediatric physiotherapists in Spain, translated into Turkish with the necessary permissions, will be used to determine the awareness levels of physiotherapists in Turkey.

Medical subject headings
Cerebral Palsy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07180017
Study groupRoleWhat they receive
1All pediatric physiotherapists working in different cities in Turkey, reached through social media under the leadership of the therapists of the Developmental Physiotherapy and Pediatric Rehabilitation Unit of Gazi University Department of Physiotherapy and Rehabilitation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Digital survey for pediatric physiotherapists(PTs)

    A purpose-built digital survey consisting of 45 multiple-choice questions with five thematic sections. The survey used in this context will be a survey administered digitally to pediatric physiotherapists in Spain, translated into Turkish with the necessary permissions. This survey will be administered via Google Forms.

    Measured: DAY1

Secondary outcomes (1)
  1. Demographic Information

    Sosyodemographic information of PTs will be recorded.

    Measured: DAY1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Sep 2025
  2. Study start1 Mar 2023
  3. Primary completion30 Mar 2024
  4. Study completion30 Apr 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Retrospective
Enrolment
105 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07180017
Sponsor's protocol ID
Survey of Turkish Pediatric PT
Status last verified
Sep 2025
First submitted
5 Sep 2025
Last updated
23 Sep 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Cerebral Palsy (CP) and Survey, run by Kahramanmaras Sutcu Imam University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Digital survey for pediatric physiotherapists(PTs) (time frame: DAY1). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
A Survey of Turkish Pediatric Physical Therapists | AzTrials